Background: In many cases, physicians initiate anti-tuberculosis (TB) treatment based only on symptoms or radiographic findings without confirmation of pulmonary TB by acid-fast bacilli (AFB) smear. It has not been well known which clinical characteristics could be used as predictors for positive culture or real TB in patients with sputum smear-negative presumptive pulmonary TB. Objective: We tried to elucidate treatment outcomes in patients with sputum smear-negative presumptive pulmonary TB and to find predictors of positive culture results. Methods: We reviewed data of the patients who had been treated as presumptive TB with negative AFB smear on the basis of clinical and radiographic features from December 1998 to December 2000 at a university hospital in Korea. We reviewed medical records and radiographs of patients and analyzed possible predictors for positive culture. Results: One hundred and one patients were enrolled. Among them, pulmonary TB was confirmed by culture in 32 patients (31%). Thirty-one (96.9%) out of 32 culture-positive patients showed clinical or radiographic improvement as did 50 (72.5%) out of 69 culture-negative patients. The predictor for a positive culture result is the presence of patchy consolidation in an initial radiograph (p = 0.025; OR 2.89; 95% CI 1.14–7.28). Conclusions: The empirical anti-TB treatment in patients with sputum smear-negative presumptive pulmonary TB was effective and adequate, especially presented with patchy consolidation in initial chest radiographs in Korea.

Keywords:
Pulmonary tuberculosis, Empirical treatment, Predictor, Radiology, Treatment outcome
1.
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677–686.
2.
Dolin PJ, Raviglione MC, Kochi A: Global tuberculosis incidence and mortality during 1990–2000. Bull World Health Organ 1994;72:213–220.
3.
Kart L, Akduman D, Altin R, Tor M, Unalacak M, Begendik F, Erdem F, Alparslan U: Fourteen-year trend of tuberculosis dynamics in the northwest of Turkey. Respiration 2003;70:468–474.
4.
Treatment of tuberculosis. Guidelines for National Programmes. WHO, 2003.
5.
Foulds J, O’Brien R: New tools for the diagnosis of tuberculosis: The perspective of developing countries. Int J Tuberc Lung Dis 1998;2:778–783.
6.
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161:1376–1395.
7.
Yeager H Jr., Lacy J, Smith LR, LeMaistre CA: Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis 1967;95:998–1004.
8.
Dutt AK, Stead WW: Smear-negative pulmonary tuberculosis. Semin Respir Infect 1994;9:113–119.
9.
Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC: The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998;2:27–36.
10.
Bah B, Massari V, Sow O, Siriwardana M, Camara LM, Larouze B, Murray JF: Useful clues to the presence of smear-negative pulmonary tuberculosis in a West African city. Int J Tuberc Lung Dis 2002;6:592–598.
11.
Aris EA, Bakari M, Chonde TM, Kitinya J, Swai AB: Diagnosis of tuberculosis in sputum negative patients in Dar es Salaam. East Afr Med J 1999;76:630–634.
12.
Kanaya AM, Glidden DV, Chambers HF: Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest 2001;120:349–355.
13.
Gordin FM, Slutkin G, Schecter G, Goodman PC, Hopewell PC: Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings. Am Rev Respir Dis 1989;139:1090–1093.
14.
Anglaret X, Saba J, Perronne C, Lacassin F, Longuet P, Leport C, Vilde JL: Empiric antituberculosis treatment: Benefits for earlier diagnosis and treatment of tuberculosis. Tuber Lung Dis 1994;75:334–340.
15.
Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, Small PM: Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444–449.
16.
Rapid diagnostic tests for tuberculosis: What is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med 1997;155:1804–1814.
17.
Brugiere O, Vokurka M, Lecossier D, Mangiapan G, Amrane A, Milleron B, Mayaud C, Cadranel J, Hance AJ: Diagnosis of smear-negative pulmonary tuberculosis using sequence capture polymerase chain reaction. Am J Respir Crit Care Med 1997;155:1478–1481.
18.
Cohen RA, Muzaffar S, Schwartz D, Bashir S, Luke S, McGartland LP, Kaul K: Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am J Respir Crit Care Med 1998;157:156–161.
19.
Salfinger M, Hale YM, Driscoll JR: Diagnostic tools in tuberculosis. Present and future. Respiration 1998;65:163–170.
20.
Daniel TM, Debanne SM, van der Kuyp F: Enzyme-linked immunosorbent assay using Mycobacterium tuberculosis antigen 5 and PPD for the serodiagnosis of tuberculosis. Chest 1985;88:388–392.
21.
Laal S, Samanich KM, Sonnenberg MG, Belisle JT, O’Leary J, Simberkoff MS, Zolla-Pazner S: Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: Antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis. J Infect Dis 1997;176:133–143.
22.
Charpin D, Herbault H, Gevaudan MJ, Saadjian M, de Micco P, Arnaud A, Vervloet D, Charpin J: Value of ELISA using A60 antigen in the diagnosis of active pulmonary tuberculosis. Am Rev Respir Dis 1990;142:380–384.
23.
Wilkins EG, Ivanyi J: Potential value of serology for diagnosis of extrapulmonary tuberculosis. Lancet 1990;336:641–644.
24.
Brandli O: The clinical presentation of tuberculosis. Respiration 1998;65:97–105.
25.
Dutt AK, Moers D, Stead WW: Smear- and culture-negative pulmonary tuberculosis: Four-month short-course chemotherapy. Am Rev Respir Dis 1989;139:867–870.
26.
Harries AD, Hargreaves NJ, Kwanjana JH, Salaniponi FM: Clinical diagnosis of smear-negative pulmonary tuberculosis: An audit of diagnostic practice in hospitals in Malawi. Int J Tuberc Lung Dis 2001;5:1143–1147.
27.
Pek WY, Chee CB, Wang YT: Bacteriologically-negative pulmonary tuberculosis – the Singapore tuberculosis control unit experience. Ann Acad Med Singapore 2002;31:92–96.
28.
Samb B, Sow PS, Kony S, Maynart-Badiane M, Diouf G, Cissokho S, Ba D, Sane M, Klotz F, Faye-Niang MA, Mboup S, Ndoye I, Delaporte E, Hane AA, Samb A, Coulaud JP, Coll-Seck AM, Larouze B, Murray JF: Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: Results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis 1999;3:330–336.
29.
Woodring JH, Vandiviere HM, Fried AM, Dillon ML, Williams TD, Melvin IG: Update: The radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol 1986;146:497–506.
30.
Georgeann M, Naidich DP: Radiology of tuberculosis; in Rom WN, Garay S (eds): Tuberculosis. Boston, Little, Brown and Company, 1996, pp 413–442.
31.
Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M: Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001;68:595–600.
32.
Fujiuchi S, Matsumoto H, Yamazaki Y, Nakao S, Takahashi M, Satoh K, Takeda A, Okamoto K, Fujita Y, Fujikane T, Shimizu T: Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease. Respiration 2003;70:76–81.
33.
Van Dyck P, Vanhoenacker FM, Van den Brande P, De Schepper AM: Imaging of pulmonary tuberculosis. Eur Radiol 2003;13:1771–1785.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.